MedTrace Logo

Evaluation of a Power Assistance Device for Wheelchair-DUO

NCT03386799 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2022-07-12

No results posted yet for this study

Summary

Power assisted wheelchairs have specific advantages compared to manual propelled or powered Wheelchair. Autonomad Mobility has developed a new device (DUO), the assistance being triggered by the motion of the wheelchair and not an push on the hand rim, people who use their foot to move or people pushing the wheelchair can be helped by the device as people propelling the wheelchair with their arms.

Furthermore DUO has an option with a longer assistance (AEP+) which can be preferred by some people.

To be referenced and reimbursed by the French health insurance, DUO has to be compared with an other power assistance device for wheelchairs, already referenced.

The study is a comparative study between DUO and the ALBER E Motion. Each patient is his own control and is assessed in 4 experimental conditions, with intervals of 3 or 4 days, manually propelled, with the E mtion device, with the DUO device and the single push configuration, with the DUO device and the AEP+ configuration.

The main outcome measure will be the user's satisfaction (using 8 items of the ESAT questionnaire)

Conditions

  • Paraplegia
  • Hemiplegia

Interventions

DEVICE

E-motion device

Powered assisted Wheelchair with the E-motion device. Outdoor and indoor runs

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • André Thevenon, MD,PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-20
Primary Completion
2021-04-21
Completion
2021-04-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03386799 on ClinicalTrials.gov